Alternaria alternata (A.tenuis) 10,000DU/ml ODC solution for skin prick test

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)

Veiklioji medžiaga:

Alternaria alternata (A.tenuis) allergen extract

Prieinama:

A.tenuis) 10,000DU/ml ODC solution for skin prick test (Allergy Therapeutics (UK) Ltd

ATC kodas:

V04CL

INN (Tarptautinis Pavadinimas):

Alternaria alternata (A.tenuis) allergen extract

Vaisto forma:

Solution for skin-prick test

Vartojimo būdas:

Intraepidermal

Klasė:

No Controlled Drug Status

Recepto tipas:

Never Valid To Prescribe As A VMP

Produkto santrauka:

BNF: 03040201

Prekės savybės

OBJECT 1
ALTERNARIA ALTERNATA 10,000 DU/ML ODC SOLUTION
FOR SKIN PRICK TEST
Summary of Product Characteristics Updated 10-Mar-2017 | Allergy
Therapeutics
1. Name of the medicinal product
_Alternaria alternata_ 10,000 DU/ml ODC
Solution for skin prick test
2. Qualitative and quantitative composition
_Alternaria alternata_ 10,000 DU/ml ODC in 2 ml
For the full list of excipients see Section 6.1.
3. Pharmaceutical form
Solution for skin prick test
A clear solution.
4. Clinical particulars
4.1 Therapeutic indications
This medicinal product is indicated for the diagnosis of allergic (IgE
– mediated) diseases (type 1 in the
classification of Coombs and Gel).
4.2 Posology and method of administration
Taking a careful case history is a vital part of the investigation of
a patient with allergy symptoms since it
will usually identify those allergens most likely to be clinically
significant. Skin testing will help to
confirm the significance of the likely causative allergens and
establish their relative importance.
Posology
_Paediatric population_
Prick testing in children is possible after the first year of life
depending on the child constitution, but in
general should not be performed before the age of 4.
Method of administration
The tests are usually carried out on the volar surface of the forearm:
In conditions of extreme outdoor
temperatures allow acclimatisation to room temperature: If test area
has been cleaned with water, alcohol
etc, wait at least two minutes to allow skin circulation to return to
normal.
Clean the skin with soap and water if necessary – but do not
sterilise with organic solvents or strong
antiseptics.
A ballpoint pen may be used to mark the skin (with suitable symbols)
adjacent to planned test sites to
identify the allergen and control solutions used.
The colours of the individual skin testing solutions vary depending on
the characteristics of the raw
material involved, e.g. pollens tend to be yellowish whilst dusts and
moulds in particular, are shades of
brown.
Since each vial is used more t